PLANET® Dose: Patient-specific, Multi-radionuclide (90Y/177Lu/131I/166Ho) & Theranostics platform for voxel-based personalized dosimetry (SIRT & MRT).
Spin-off between Gustave Roussy & Institut Curie, DOSIsoft was founded in 2002. It develops patient-specific imaging and dosimetry software in Radiation Oncology & Nuclear Medicine to improve patient safety & treatment quality. More than 20 years of innovation and R&D investments have led to world leading software used in over 600 hospital centers in 60 countries.
PLANET® is a Patient-specific, multi-radionuclide (90Y/177Lu/131I/166Ho) dosimetry & theranostics platform. It comprises:
PLANET® Onco: Oncology software for Molecular Imaging (MI) & Radiotherapy. It helps to optimize disease diagnosis & therapy through registration, contouring, advanced quantification & patient response from multimodal imaging. Texture analysis for diagnosis, follow-up & radiomics is provided.
PLANET® Dose: Dosimetry software for SIRT and Molecular RadioTherapy (MRT) providing multiple and integrated workflow for 90Y/177Lu/131I/166Ho dosimetry. It allows to personalize patient therapy through pre/post-implementation dosimetry, automatic structure propagation, calculation of residence time & comparison between treatment planning & validation control dose maps. Consolidation of multi-treatment stages is available.
Brands: PLANET Dose - Patient QA with ThinkQA Secondary Dose Check, EPIbeam pretreatment verification and EPIgray® in vivo dosimetry.
Products